← Leaderboards
Jay Yang
University Of Rochester
$8,324,911
Attributed
$10,531,029
Total exposure
8
Grants
4
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $1.2M · FY2005–17$2M$1.5M$1M$500K$0
'05
'06
'07
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
Funding mix
By agency
NIH$10,531,029 · 8
By mechanism
R01$10,531,029 · 8
Top collaborators
- Jun-Ichi Abe8 shared
- Arnold E. Ruoho4 shared
Others in their field
Top investigators on “In Vivo”
- David Heimbrook · Leidos Biomedical Research, Inc.$371,850,582
- Leonard Freedman · Leidos Biomedical Research, Inc.$304,459,298
- Dennis R. Burton · Scripps Research Institute$212,708,174
- Mark S Klempner · Tufts Medical Center$128,021,180
- Florian Krammer · Icahn School Of Medicine At Mount Sinai$104,723,856
- David M. Margolis · University Of Texas Sw Med Ctr/Dallas$98,374,200
Research focus
In VivoMediatingMolecularBaseSignal TransductionPlayResearch PersonnelResearch StudyYangReportingInnovationUniversitiesArtsEnvironmentInjuryIn VitroBiochemicalPhosphorylationApoptosisBinding (Molecular Function)AnimalsCollaborationsMortality Vital StatisticsCells
Grant awards (31)
Treatment for neuropathic pain targeting selective inhibition of MEK$285,950
R01 · FY2017 · GM · contact PI
Sigma 1 receptor as a master regulator of pronociceptive protein trafficking in t$285,950
R01 · FY2016 · GM · contact PI
Treatment for neuropathic pain targeting selective inhibition of MEK$285,950
R01 · FY2016 · GM · contact PI
Treatment for neuropathic pain targeting selective inhibition of MEK$285,950
R01 · FY2015 · GM · contact PI
Sigma 1 receptor as a master regulator of pronociceptive protein trafficking in t$285,950
R01 · FY2015 · GM · contact PI
Treatment for neuropathic pain targeting selective inhibition of MEK$285,950
R01 · FY2014 · GM · contact PI
Sigma 1 receptor as a master regulator of pronociceptive protein trafficking in t$285,950
R01 · FY2014 · GM · contact PI
Ubiquitin-like protein modification in diabetic cardiomyopathy$126,063
R01 · FY2014 · HL
Ubiquitin-like protein modification in diabetic cardiomyopathy$366,758
R01 · FY2013 · HL
Sigma 1 receptor as a master regulator of pronociceptive protein trafficking in t$285,950
R01 · FY2013 · GM · contact PI
Ubiquitin-like protein modification in diabetic cardiomyopathy$385,250
R01 · FY2012 · HL
Kinases-mediated SUMOylation in Diabetic Cardiomyopathy$501,168
R01 · FY2011 · HL
Ubiquitin-like protein modification in diabetic cardiomyopathy$398,875
R01 · FY2011 · HL
Mitochondrial Kv1.3 potassium channels and lymphocyte apoptosis in sepsis$291,090
R01 · FY2011 · GM · contact PI
Kinases-mediated SUMOylation in Diabetic Cardiomyopathy$488,243
R01 · FY2010 · HL
Mitochondrial Kv1.3 potassium channels and lymphocyte apoptosis in sepsis$294,030
R01 · FY2010 · GM · contact PI
Kinases-mediated SUMOylation in Diabetic Cardiomyopathy$485,124
R01 · FY2009 · HL
Mitochondrial Kv1.3 potassium channels and lymphocyte apoptosis in sepsis$297,000
R01 · FY2009 · GM · contact PI
Kinases-mediated SUMOylation in Diabetic Cardiomyopathy$516,955
R01 · FY2008 · HL
Big MAP Kinase 1-Cx 43 Signaling in Ischemia Injury$355,969
R01 · FY2008 · GM · contact PI
Mitochondrial Kv1.3 potassium channels and lymphocyte apoptosis in sepsis$320,600
R01 · FY2008 · GM · contact PI
Big MAP Kinase 1-Cx 43 Signaling in Ischemia Injury$356,090
R01 · FY2007 · GM · contact PI
Big MAP Kinase 1-Cx 43 Signaling in Ischemia Injury$356,215
R01 · FY2006 · GM · contact PI
Big MAP Kinase 1-Cx 43 Signaling in Ischemia Injury$400,847
R01 · FY2005 · GM
Modulation of SNS Sodium Channel by Phosphorylation$371,592
R01 · FY2005 · NS
Modulation of SNS Sodium Channel by Phosphorylation$372,080
R01 · FY2004 · NS
Modulation of SNS Sodium Channel by Phosphorylation$372,554
R01 · FY2003 · NS
Modulation of SNS Sodium Channel by Phosphorylation$388,094
R01 · FY2002 · NS
GABAA RECEPTOR BETA-SUBUNIT AND GENERAL ANESTHETICS$277,950
R01 · FY2002 · GM
GABAA RECEPTOR BETA-SUBUNIT AND GENERAL ANESTHETICS$260,441
R01 · FY2001 · GM
GABAA RECEPTOR BETA-SUBUNIT AND GENERAL ANESTHETICS$260,441
R01 · FY2000 · GM